1,715
Views
0
CrossRef citations to date
0
Altmetric
Drug Profile

Complement-directed therapy for cold agglutinin disease: sutimlimab

Pages 479-494 | Received 01 Mar 2023, Accepted 23 May 2023, Published online: 02 Jun 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.